Skip to main content
Log in

Influence of intravesical administration of tumor necrosis factor α and systemic γ-interferon on murine bladder cancer: Lack of dose response

  • Original Articles
  • Published:
Urological Research Aims and scope Submit manuscript

Summary

The effect of intravesical administration of high dose recombinant tumor necrosis factor-α (rTNF) and in combination with systemic recombinant γ-interferon (rIFN) on murine bladder cancer was studied. RTNF was given at 12.5 μg/mouse on days 7, 11 and 15 after tumor instillation or at 2.5 μg/mouse on days 7, 9, 11, 13 and 15. Some groups were also injected i.v., 24-h prior to each rTNF treatment with rIFN at a dose of 1.3 μg/mouse. RTNF treatment suppressed tumor growth up to 48% of control, although the difference was not statistically significant. Combined administration of rIFN did not provide additional benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Balkwill FR, Lee A, Aldam G, Moodie E, Thomas JA, Tavernier J, Fiers W (1986) Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res 46:3990

    Google Scholar 

  2. Fransen L, Vander Heyden J, Ruysschaert R, Fiers W (1986) Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell lines. Eur J Cancer Clin Oncol 22:419

    Google Scholar 

  3. Jain RK (1987) Transport of molecules in the tumor interstitium: a review. Cancer Res 47:3039

    Google Scholar 

  4. Lee K, Ewing JF, Sluss PM (1989) Effect of bacterial lipopolysaccaride on growth of murine bladder cancer, MBT-2. Urol Res 17:285

    Google Scholar 

  5. Lee K, O'Donnell RW, Schoen S, Cockett ATKC (1987) Effect of intravesical administration of tumor necrosis serum and human recombinant tumr necrosis factor on a murine bladder tumor. J Urol 138:430

    Google Scholar 

  6. O'Donnell RW, Laluppa JC, Lee K (1988) In vitro effect of tumor necrosis factor-alpha, interferon-gamma and macrophages on murine bladder tumor (MBT-2) cells. Proc Am Assoc Cancer Res 29:368 (Abstract 1464)

    Google Scholar 

  7. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV (1984) Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312:724

    Google Scholar 

  8. Schiller JH, Bitlner G, Storer B, Willson JK (1987) Synergistic antitumor effects of tumor necrosis factor and γ-interferon on colon carcinoma cell lines. Cancer Res 47:2809

    Google Scholar 

  9. Soloway MS (1977) Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res 17:2918

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, K., O'Donnell, R.W. & Cockett, A.T.K. Influence of intravesical administration of tumor necrosis factor α and systemic γ-interferon on murine bladder cancer: Lack of dose response. Urol. Res. 18, 287–289 (1990). https://doi.org/10.1007/BF00294775

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00294775

Key words

Navigation